These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23131031)

  • 21. Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean models.
    Cecil A; Gentschev I; Adelfinger M; Dandekar T; Szalay AA
    Bioengineered; 2019 Dec; 10(1):190-196. PubMed ID: 31142183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
    Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporter.
    Haddad D; Chen CH; Carlin S; Silberhumer G; Chen NG; Zhang Q; Longo V; Carpenter SG; Mittra A; Carson J; Au J; Gonen M; Zanzonico PB; Szalay AA; Fong Y
    PLoS One; 2012; 7(8):e41647. PubMed ID: 22912675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation.
    Zhang Q; Liang C; Yu YA; Chen N; Dandekar T; Szalay AA
    Mol Genet Genomics; 2009 Oct; 282(4):417-35. PubMed ID: 19701652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.
    Yu YA; Galanis C; Woo Y; Chen N; Zhang Q; Fong Y; Szalay AA
    Mol Cancer Ther; 2009 Jan; 8(1):141-51. PubMed ID: 19139123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.
    Worschech A; Chen N; Yu YA; Zhang Q; Pos Z; Weibel S; Raab V; Sabatino M; Monaco A; Liu H; Monsurró V; Buller RM; Stroncek DF; Wang E; Szalay AA; Marincola FM
    BMC Genomics; 2009 Jul; 10():301. PubMed ID: 19583830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy.
    Hikichi M; Kidokoro M; Haraguchi T; Iba H; Shida H; Tahara H; Nakamura T
    Mol Ther; 2011 Jun; 19(6):1107-15. PubMed ID: 21386827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA-Seq Based Transcriptome Analysis of the Type I Interferon Host Response upon Vaccinia Virus Infection of Mouse Cells.
    Hernáez B; Alonso G; Alonso-Lobo JM; Rastrojo A; Fischer C; Sauer S; Aguado B; Alcamí A
    J Immunol Res; 2017; 2017():5157626. PubMed ID: 28280747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and testing of novel oncolytic vaccinia strains.
    Thorne SH
    Methods Mol Biol; 2009; 542():635-47. PubMed ID: 19565925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replication and virus-induced transcriptome of HAdV-5 in normal host cells versus cancer cells--differences of relevance for adenoviral oncolysis.
    Dorer DE; Holtrup F; Fellenberg K; Kaufmann JK; Engelhardt S; Hoheisel JD; Nettelbeck DM
    PLoS One; 2011; 6(11):e27934. PubMed ID: 22140489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncolytic cancer therapy with a vaccinia virus strain.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B; Hu Z
    Oncol Rep; 2019 Jan; 41(1):686-692. PubMed ID: 30365140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma.
    Pugalenthi A; Mojica K; Ady JW; Johnsen C; Love D; Chen NG; Aguilar RJ; Szalay AA; Fong Y
    Cancer Gene Ther; 2015 Dec; 22(12):591-6. PubMed ID: 26584530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
    Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccinia Virus Arrests and Shifts the Cell Cycle.
    Martin CK; Samolej J; Olson AT; Bertoli C; Wiebe MS; de Bruin RAM; Mercer J
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35216024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen profiling analysis of vaccinia virus injected canine tumors: oncolytic virus efficiency predicted by boolean models.
    Cecil A; Gentschev I; Adelfinger M; Nolte I; Dandekar T; Szalay AA
    Bioengineered; 2014; 5(5):319-25. PubMed ID: 25482233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms.
    Kloker LD; Berchtold S; Smirnow I; Beil J; Krieg A; Sipos B; Lauer UM
    BMC Cancer; 2020 Jul; 20(1):628. PubMed ID: 32631270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Features of the Antitumor Effect of Vaccinia Virus Lister Strain.
    Zonov E; Kochneva G; Yunusova A; Grazhdantseva A; Richter V; Ryabchikova E
    Viruses; 2016 Jan; 8(1):. PubMed ID: 26771631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification from diverse mammalian poxviruses of host-range regulatory genes functioning equivalently to vaccinia virus C7L.
    Meng X; Chao J; Xiang Y
    Virology; 2008 Mar; 372(2):372-83. PubMed ID: 18054061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposing Roles of Double-Stranded RNA Effector Pathways and Viral Defense Proteins Revealed with CRISPR-Cas9 Knockout Cell Lines and Vaccinia Virus Mutants.
    Liu R; Moss B
    J Virol; 2016 Sep; 90(17):7864-79. PubMed ID: 27334583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody.
    Patil SS; Gentschev I; Adelfinger M; Donat U; Hess M; Weibel S; Nolte I; Frentzen A; Szalay AA
    PLoS One; 2012; 7(10):e47472. PubMed ID: 23091626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.